The lawsuit for removal of directors at Dongseong Pharmaceutical (Case No. 2025가합20903) has been concluded via a court-recommended settlement.
Under the settlement, two defendant directors (N and W) resigned from their positions, and the plaintiff (Brand Refactoring Co.) abandoned the remaining claims.
Each party bears its own litigation costs.
Decision date: April 24, 2026; Confirmation date: May 14, 2026 (no objection filed).
This follows the initial disclosure of the management dispute lawsuit on Oct 30, 2025; the resolution removes legal uncertainty.